| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2016-02-02 | Zika virus vaccine | Zika virus infection | Sanofi Pasteur (France) | Infectious diseases | |
| 2016-02-02 | Zika virus infection | NewLink Genetics (USA - IO) | Infectious diseases | ||
| 2016-02-01 | Defitelio®(defibrotide) | severe veno-occlusive disease (VOD) in patients undergoing haematopoietic (blood) stem-cell transplantation | 3 | Jazz Pharmaceuticals (Ireland) | Cardiovascular diseases - Rare diseases |
| 2016-01-29 | CAR-T cell programme | undisclosed | 1 | Oxford BioMedica (UK) Novartis (Switzerland) | undisclosed |
| 2016-01-29 | BioChaperone Lispro U100 | 1b | Adocia (France) Eli Lilly (USA - IN) | Metabolic diseases | |
| 2016-01-28 | ARQ 092 | Proteus syndrome | 1 | ArQule (USA - MA) | Rare diseases - Genetic diseases |
| 2016-01-28 | ARQ 751 | advanced solid tumors | 1 | ArQule (USA - MA) | Cancer - Oncology |
| 2016-01-28 | elagolix | uterine fibroids | 3 | Abbvie (USA - IL) Neurocrine Biosciences (USA - CA) | Women health |
| 2016-01-28 | MERS vaccine (GLS-5300) | Middle East respiratory syndrome (MERS) | 1 | Inovio Pharmaceuticals (USA - PA) GeneOne Life Science (Republic of Korea) | Infectious diseases - Respiratory diseases |
| 2016-01-27 | BIND-014 (docetaxel encapsulated in a polymeric nanoparticle) | non-small cell lung cancer (NSCLC) patients with KRAS mutant tumors (mutated Kirsten ras oncogene homolog) or squamous histology | 2 | Bind Therapeutics (USA - MA) | Cancer - Oncology |
| 2016-01-27 | rociletinib (CO-1686) and atezolizumab (MPDL3280A) | advanced EGFR-mutant non-small cell lung cancer (NSCLC) | 1b-2 | Clovis Oncology (USA - CO) Genentech, a member of Roche Group (USA - CA - Switzerland) | Cancer - Oncology |
| 2016-01-27 | pamrevlumab (FG-3019) | unresectable pancreatic cancer | 1-2 | FibroGen (USA - CA) | Cancer - Oncology |
| 2016-01-26 | IFX-1 | severe sepsis, septic shock | 2 | InflaRx (Germany) | Inflammatory diseases |
| 2016-01-26 | GLPG1205 | moderate to severe ulcerative colitis | 2 | Galapagos (Belgium) | Autoimmune diseases - Inflammatory diseases - Digestive diseases |
| 2016-01-26 | Dysport® (abobotulinumtoxin A ) | lower limb spasticity/dynamic equinus foot deformity in children and in adults | 3 | Ipsen (France) | Neurological diseases - Neuromuscular diseases |
| 2016-01-26 | Xtandi® (enzalutamide) and bicalutamide | prostate cancer | 2 | Medivation (USA - CA) Astellas (Japan) | Cancer - Oncology |
| 2016-01-25 | Tookad® (padeliporfin di-potassium) | low-risk prostate cancer | 3 | Steba Biotech (Luxembourg) | Cancer - Oncology |
| 2016-01-25 | tarextumab (anti-Notch 2/3, OMP-59R5) | pancreatic cancer | 2 | OncoMed Pharmaceuticals (USA - CA) Morphosys (Germany) | Cancer - Oncology |
| 2016-01-22 | indoximod | metastatic pancreatic cancer | 1-2 | NewLink Genetics (USA - IO) | Cancer - Oncology |
| 2016-01-22 | demcizumab | pancreatic cancer | 1b | OncoMed Pharmaceuticals (USA - CA) | Cancer - Oncology |
